跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 55 条关于
“PYK2”
全部
55
临床试验
8
药物
12
机构
0
资讯
35
去年
Verastem Oncology's RAMP 203 Trial Shows Encouraging Initial Data for Triplet Combination in Advanced KRAS G12C Mutant NSCLC
6个月前
Dual Drug Combinations Show Promise in Overcoming Multiple Myeloma Resistance
去年
Verastem Oncology to Present New LGSOC Treatment Data at SGO 2025 Annual Meeting
去年
Verastem Oncology Refinances Debt and Advances Avutometinib/Defactinib Combination
2年前
Verastem Oncology's Avutometinib and Defactinib Combination Receives FDA Priority Review for Recurrent KRAS Mutant LGSOC
去年
Verastem Oncology Gears Up for Potential 2025 Launch of Avutometinib Plus Defactinib in KRAS Mutant LGSOC
去年
Novel Oral Psoriasis Therapies Show Promise: TYK2 Inhibitors Lead Breakthrough Advances
去年
Takeda's Oral TYK2 Inhibitor Zasocitinib Advances Development for Multiple Autoimmune Conditions
去年
Bristol Myers' TYK2 Inhibitor Shows Promise in Phase 3 Psoriatic Arthritis Trials
去年
Sareum Holdings Raises £2.4 Million to Advance TYK2/JAK1 Inhibitor SDC-1801
第 1 页,共 4 页
上一页
下一页